Search for: "TWI Pharmaceuticals, Inc"
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
14 Oct 2018, 9:59 pm
TWi Pharmaceuticals, Inc., the Federal Circuit affirmed a decision by the U.S. [read post]
3 Dec 2014, 9:59 pm
TWI Pharmaceuticals, Inc., where the patentee prevailed only to face almost certain defeat on remand. [read post]
23 Feb 2017, 12:16 pm
Two Defendants are listed, TWi Pharmaceuticals, Inc. of Paramus, New Jersey and TWi Pharmaceuticals USA, Inc. of Taipei, Taiwan. [read post]
16 Aug 2017, 8:08 am
District Judge Renee Marie Bumb found that if Taiwanese firm Twi Pharmaceuticals Inc. [read post]
6 Sep 2018, 5:38 pm
The CAFC affirmed DNJ in the TWi/Supernus case:TWi Pharmaceuticals, Inc. [read post]
5 Sep 2011, 9:36 pm
• Defendant: TWi Pharmaceuticals, Inc. [read post]
25 Aug 2013, 9:21 pm
• Defendant: TWi Pharmaceuticals, Inc. [read post]
4 Dec 2014, 10:00 pm
In Par Pharmaceutical Inc. v. [read post]
12 Sep 2015, 8:01 am
Robinson in Par Pharmaceutical, Inc., et al. v. [read post]
24 Oct 2017, 4:15 am
TWi Pharmaceuticals, Inc., 773 F.3d 1186 (2014). [read post]
21 Aug 2015, 11:16 am
Twi Pharmaceuticals, Inc.]Also, from a 2012 IPBiz postAppellants are also correct that employment of inherency is incorrect in a § 103 analysis when it is not known in the art that the inherent part is in fact inherent. [read post]
20 Aug 2014, 7:08 am
TWi Pharmaceuticals, Inc., 1-11-cv-02466 (MDD August 12, 2014, Order) (Blake, J.) [read post]
3 Aug 2015, 6:50 am
TWi Pharmaceuticals, Inc., 1-11-cv-02466 (MDD July 30, 2015, Order) (Blake, J.) [read post]
14 May 2019, 11:24 am
TWI Pharm., Inc., 773 F.3d 1186, 1196 (Fed. [read post]
17 Jul 2018, 9:28 am
TWI Pharmaceutical, Inc., 773 F.3d 1186 (Fed. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
